Accelerating discoveries for better health
On July 19, 2021, admitting providers were offered the additional option to allow asymptomatic subjects to COVID swab upon admission. We are now pleased extend this offer to the 9B space starting Friday, September 3rd, 2021. Any subjects not planning to have their pre-swab completed/uploaded within 72 hours of admissions will need a COVID ORDER added […]
Important Update on COVID Swab Requirement for 9B Read More »
For study teams: Please be sure to site the Clinical Research Center grants from NIH-NCATS when publishing any papers that received support from the CRC. Please also send any CCI publication citations to cci@bwh.harvard.edu , as this information is also required for the CCI/Catalyst Progress reports to the NIH. Note that we are only referring to Federal
Referencing CCI Grant Numbers on Publications Read More »
The CCI recently opened a BL2+ lab on BWH’s main campus to process infectious samples, including COVID+ samples. This lab has 2 biosafety cabinets, centrifuges with sealed rotors, and an incubator. The equipment will allow investigators to study biological sampling of blood, nasal and lower respiratory secretions in order to identify immunophenotypic and genomic features.
NEW CCI BL2+ lab for Infectious Samples Processing Read More »
CCI FY21 prices have been established and will be effective starting October 1, 2020. All prices for FY21 will remain the same as FY20 with the exception of telemetry and the industry rate for Phlebotomy/EKG/Vitals training. Please don’t hesitate to contact us at CCI@bwh.harvard.edu with any questions or concerns.